Dr. Josep Tabernero
Director at Vall d'Hebron Institute of Oncology (VHIO), Spain
Josep Tabernero holds MD and PhD degrees from the Universitat Autònoma de Barcelona, Spain, and he is currently Head of the Medical Oncology Department at the Vall d’Hebron University Hospital, Director of the Vall d’Hebron Institute of Oncology (VHIO) and Professor of Medicine at UVic-UCC. He has been Principal Investigator of several Phase I pharmacodynamic studies and translational projects with tumor-directed targeted therapies and immune-based therapies. He has (co) authored approximately 500 peer-reviewed papers. He was the President (2018 – 2019) and is currently the Past President (2020-2021) of the European Society for Medical Oncology (ESMO), and serves on its Public Policy as well as Cancer Medicines Committees. He is also member of the American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO). He has been a member of the Educational and Scientific Committees of the ESMO, ASCO, AACR, AACR/NCI/EORTC, ASCO Gastrointestinal, and WCGIC meetings.
Parallel Session: Clinical and translational research as a way to promote sustainable and rapid access to innovation
- 10 November, 2021
- 11:00 - 12:30